These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8596297)

  • 1. Safety of combined oral contraceptive pills.
    Cramer DW
    Lancet; 1996 Feb; 347(9000):546-8. PubMed ID: 8596297
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral contraceptives and venous thromboembolism.
    Graham A; Grieve F; Davie J; Glasier A
    Lancet; 1995 Nov; 346(8987):1430. PubMed ID: 7475846
    [No Abstract]   [Full Text] [Related]  

  • 3. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 4. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
    Surico N; Porcelli A; Petrelli P; Amedeo M; Crivello T; Ferraris G
    Minerva Ginecol; 1988 Sep; 40(9):559-62. PubMed ID: 2975773
    [No Abstract]   [Full Text] [Related]  

  • 6. Desogestrel, gestodene contraceptives may carry greater thromboembolic risk.
    Am J Health Syst Pharm; 1996 Feb; 53(3):228. PubMed ID: 8808016
    [No Abstract]   [Full Text] [Related]  

  • 7. Newer oral contraceptives and the risk of venous thromboembolism.
    Walker AM
    Contraception; 1998 Mar; 57(3):169-81. PubMed ID: 9617533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets.
    Dinger J; Shapiro S
    J Fam Plann Reprod Health Care; 2012 Jan; 38(1):2-6. PubMed ID: 22128104
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of modern oral contraceptives.
    Henzl MR
    Lancet; 1996 Jan; 347(8996):257-8. PubMed ID: 8551892
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral contraceptives and venous thromboembolism: an epidemiological review.
    Lidegaard O
    Eur J Contracept Reprod Health Care; 1996; 1(1):13-20. PubMed ID: 9678133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comments on desogestrel and gestoden (3rd generation progestogens) and the incidence of thromboembolism.
    Lauritzen C
    Horm Metab Res; 1996 May; 28(5):245-7. PubMed ID: 8738115
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of acute myocardial infarction and low-dose combined oral contraceptives.
    Jick H; Jick S; Myers MW; Vasilakis C
    Lancet; 1996 Mar; 347(9001):627-8. PubMed ID: 8596366
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety of modern oral contraceptives. The International Committee for Research in Reproduction.
    Johannisson E
    Lancet; 1996 Jan; 347(8996):258. PubMed ID: 8551893
    [No Abstract]   [Full Text] [Related]  

  • 14. Third generation oral contraceptives containing desogestrel and gestodene and the risk of thrombosis.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):5-7. PubMed ID: 8920631
    [No Abstract]   [Full Text] [Related]  

  • 15. Third generation oral contraceptives.
    Skegg DC
    BMJ; 2000 Jul; 321(7255):190-1. PubMed ID: 10903631
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of combined oral contraceptive pills.
    de Lignieres B
    Lancet; 1996 Feb; 347(9000):548-9. PubMed ID: 8596298
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1995 Dec; 346(8990):1582-8. PubMed ID: 7500749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of combined oral contraceptive pills.
    Plu-Bureau G; Amiral J; Guize L; Scarabin PY
    Lancet; 1996 Feb; 347(9000):549. PubMed ID: 8596299
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H; Jick SS; Gurewich V; Myers MW; Vasilakis C
    Lancet; 1995 Dec; 346(8990):1589-93. PubMed ID: 7500750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for prescribing combined oral contraceptives.
    Mills AM; Wilkinson CL; Bromham DR; Elias J; Fotherby K; Guillebaud J; Kubba A; Wade A
    BMJ; 1996 Jan; 312(7023):121-2. PubMed ID: 8555906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.